We have previously shown that baseline CRP, with a cut‐off of 10 mg/L, is a very strong indicator for prognosis in ICI treated multiple advanced cancer types and the identification and validation of the CRP cut‐off is explained in detail in our previous publication.26 The gene discussed is CRP; the disease is cancer.